Labeler
Cipla USA Inc. NDC Codes
Cipla USA Inc. lists 269 finished drug products in the FDA NDC Directory under NDC labeler code 69097.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Lanreotide Acetate, Diltiazem Hydrochloride, Lenalidomide, Lurasidone Hydrochloride, Pomalidomide, Phytonadione, Pravastatin Sodium, Fluticasone propionate and Salmeterol, Nilotinib, Potassium Phosphates, Vilazodone Hydrochloride, Pirfenidone, Deferasirox, Lanthanum carbonate, Dapagliflozin
- Active ingredients
- Lanreotide acetate, Diltiazem hydrochloride, Lenalidomide, Lurasidone hydrochloride, Pomalidomide, Phytonadione, Pravastatin sodium, Fluticasone propionate, Salmeterol xinafoate, Nilotinib, Monobasic potassium phosphate, Dibasic potassium phosphate
- NDC labeler codes
- 69097
- Strengths (from the 100 most recently listed products)
- Salmeterol xinafoate 50 ug/1; Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL; Liraglutide 6 mg/mL; Lanreotide acetate 120 mg/.5mL; Lanreotide acetate 60 mg/.2mL; Lanreotide acetate 90 mg/.3mL; Phytonadione 1 mg/.5mL; Pirfenidone 267 mg/1; Cyclosporine .5 mg/mL; Pomalidomide 1 mg/1; Pomalidomide 2 mg/1; Pomalidomide 3 mg/1; Pomalidomide 4 mg/1; Fluticasone propionate 250 ug/1; Fluticasone propionate 100 ug/1; Fluticasone propionate 500 ug/1; Albuterol sulfate 90 ug/1; Dapagliflozin propanediol 5 mg/1; Dapagliflozin propanediol 10 mg/1
- Dosage forms
- Capsule, Tablet, Film coated, Injection, Tablet, Tablet, Extended release, Powder, Injection, Solution, Injection, Emulsion, For suspension, Granule, Tablet, Chewable, Emulsion, Kit, Suspension, Tablet, Film coated, Extended release, Tablet, Coated, Aerosol, Metered, Injection, Powder, Lyophilized, For suspension, Gel, Granule, For solution, Solution
- Routes
- Oral, Subcutaneous, Intravenous, Intramuscular, Respiratory (Inhalation), Ophthalmic, Topical
- Drug classes (FDA established)
- Thalidomide Analog, Somatostatin Analog, Osmotic Laxative, Potassium Salt, Calcium Channel Blocker, beta2-Adrenergic Agonist, Kinase Inhibitor, Atypical Antipsychotic, Corticosteroid, Vitamin K, Warfarin Reversal Agent, HMG-CoA Reductase Inhibitor, Proton Pump Inhibitor, Protease Inhibitor, Pyridone, Iron Chelator, Phosphate Binder, Sodium-Glucose Cotransporter 2 Inhibitor, GLP-1 Receptor Agonist, Leukocyte Growth Factor, P2Y12 Platelet Inhibitor, Serotonin Reuptake Inhibitor, Serotonin-4 Receptor Agonist, Dihydropyridine Calcium Channel Blocker, Aminoketone, Androgen, Nucleoside Metabolic Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Calcineurin Inhibitor Immunosuppressant, Microtubule Inhibitor, Penicillin-class Antibacterial, beta Lactamase Inhibitor, Calcitonin, Nonsteroidal Anti-inflammatory Drug, Muscle Relaxant, Neuraminidase Inhibitor, Cytochrome P450 3A Inhibitor, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 136 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Meprobamate | Meprobamate 400 mg/1 | TabletOral | 69097-975 | 69097-0975-07 | — |
| Emtricitabine And Tenofovir Disoproxil Fumarate | Emtricitabine 200 mg/1; Tenofovir disoproxil fumarate 300 mg/1 | Tablet, Film coatedOral | 69097-209 | 69097-0209-02 | — |
| efavirenz, emtricitabine and tenofovir disoproxil fumarate | Efavirenz 600 mg/1 + 2 more ingredients | Tablet, Film coatedOral | 69097-210 | 69097-0210-02 | — |
| Sumatriptan | Sumatriptan 20 mg/1 | SprayNasal | 69097-644 | 69097-0644-48 | — |
| Tavaborole | Tavaborole 43.5 mg/mL | SolutionTopical | 69097-686 | 69097-0686-37 | — |
| Terbinafine Hydrochlorideterbinafine tablets 250 mg | Terbinafine hydrochloride 250 mg/1 | TabletOral | 69097-731 | 69097-0731-0269097-0731-07 | — |
| Dimethyl Fumarate | Dimethyl fumarate 120 mg/1 | Capsule, Delayed releaseOral | 69097-322 | 69097-0322-89 | — |
| Dimethyl Fumarate | Dimethyl fumarate 240 mg/1 | Capsule, Delayed releaseOral | 69097-323 | 69097-0323-03 | — |
| Dimethyl Fumarate | — | Kit | 69097-552 | 69097-0552-03 | — |
| emtricitabine | Emtricitabine 200 mg/1 | CapsuleOral | 69097-642 | 69097-0642-02 | — |
| Fosinopril Sodium and Hydrochlorothiazide | Fosinopril sodium 10 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | 69097-972 | 69097-0972-07 | — |
| Fosinopril Sodium and Hydrochlorothiazide | Fosinopril sodium 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | 69097-973 | 69097-0973-07 | — |
| Icatibant | Icatibant acetate 30 mg/3mL | InjectionSubcutaneous | 69097-664 | 69097-0664-3469097-0664-68 | — |
| Sildenafil | Sildenafil citrate 25 mg/1 | TabletOral | 69097-951 | 69097-0951-02 | — |
| Sildenafil | Sildenafil citrate 50 mg/1 | TabletOral | 69097-952 | 69097-0952-0269097-0952-07 | — |
| Sildenafil | Sildenafil citrate 100 mg/1 | TabletOral | 69097-953 | 69097-0953-0269097-0953-07 | — |
| Ipratropium Bromide and Albuterol Sulfate | Ipratropium bromide .5 mg/3mL; Albuterol sulfate 2.5 mg/3mL | SolutionRespiratory (Inhalation) | 69097-840 | 69097-0840-5369097-0840-6469097-0840-87 | — |
| Dihydroergotamine Mesylate Nasal | Dihydroergotamine mesylate 4 mg/mL | Spray, MeteredNasal | 69097-503 | 69097-0503-2769097-0503-31 | — |
| Albuterol Sulfate | Albuterol sulfate 90 ug/1 | InhalantRespiratory (Inhalation) | 69097-142 | 69097-0142-60 | — |
| Esomeprazole Magnesium | Esomeprazole magnesium 10 mg/1 | Granule, For suspension, Extended releaseOral | 69097-527 | 69097-0527-34 | — |
| Esomeprazole magnesium | Esomeprazole magnesium dihydrate 20 mg/1 | For suspensionOral | 69097-528 | 69097-0528-34 | — |
| Esomeprazole magnesium | Esomeprazole magnesium dihydrate 40 mg/1 | For suspensionOral | 69097-529 | 69097-0529-34 | — |
| PREGABALIN capsules, CV | Pregabalin 25 mg/1 | CapsuleOral | 69097-677 | 69097-0677-05 | — |
| PREGABALIN capsules, CV | Pregabalin 50 mg/1 | CapsuleOral | 69097-678 | 69097-0678-05 | — |
| PREGABALIN capsules, CV | Pregabalin 75 mg/1 | CapsuleOral | 69097-679 | 69097-0679-05 | — |
| PREGABALIN capsules, CV | Pregabalin 100 mg/1 | CapsuleOral | 69097-681 | 69097-0681-05 | — |
| PREGABALIN capsules, CV | Pregabalin 150 mg/1 | CapsuleOral | 69097-682 | 69097-0682-05 | — |
| PREGABALIN capsules, CV | Pregabalin 200 mg/1 | CapsuleOral | 69097-683 | 69097-0683-05 | — |
| PREGABALIN capsules, CV | Pregabalin 225 mg/1 | CapsuleOral | 69097-684 | 69097-0684-05 | — |
| PREGABALIN capsules, CV | Pregabalin 300 mg/1 | CapsuleOral | 69097-685 | 69097-0685-05 | — |
| Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets | Lisinopril 10 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | 69097-968 | 69097-0968-0569097-0968-0769097-0968-12+1 more | — |
| Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets | Lisinopril 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | 69097-969 | 69097-0969-0569097-0969-0769097-0969-12+1 more | — |
| Lisinopril and Hydrochlorothiazidelisinopril and hydrochlorothiazide tablets | Lisinopril 20 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | 69097-971 | 69097-0971-0569097-0971-0769097-0971-12+1 more | — |
| Vigabatrin | Vigabatrin 500 mg/mL | Powder, For solutionOral | 69097-964 | 69097-0964-53 | — |
| Pregabalin | Pregabalin 25 mg/1 | CapsuleOral | 69097-954 | 69097-0954-0569097-0954-12 | — |
| Pregabalin | Pregabalin 50 mg/1 | CapsuleOral | 69097-955 | 69097-0955-0569097-0955-12 | — |
| Pregabalin | Pregabalin 75 mg/1 | CapsuleOral | 69097-956 | 69097-0956-0569097-0956-12 | — |
| Pregabalin | Pregabalin 100 mg/1 | CapsuleOral | 69097-957 | 69097-0957-0569097-0957-12 | — |
| Pregabalin | Pregabalin 150 mg/1 | CapsuleOral | 69097-958 | 69097-0958-0569097-0958-12 | — |
| Pregabalin | Pregabalin 200 mg/1 | CapsuleOral | 69097-959 | 69097-0959-05 | — |
| Pregabalin | Pregabalin 225 mg/1 | CapsuleOral | 69097-961 | 69097-0961-05 | — |
| Pregabalin | Pregabalin 300 mg/1 | CapsuleOral | 69097-962 | 69097-0962-05 | — |
| Ambrisentan | Ambrisentan 5 mg/1 | Tablet, Film coatedOral | 69097-386 | 69097-0386-0269097-0386-19 | — |
| Ambrisentan | Ambrisentan 10 mg/1 | Tablet, Film coatedOral | 69097-387 | 69097-0387-0269097-0387-19 | — |
| Testosterone Cypionate | Testosterone cypionate 200 mg/mL | Injection, SolutionIntramuscular | 69097-802 | 69097-0802-3269097-0802-37 | — |
| Metoprolol Succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | 69097-407 | 69097-0407-0269097-0407-0769097-0407-15 | — |
| Metoprolol Succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | 69097-408 | 69097-0408-0269097-0408-0769097-0408-15 | — |
| Metoprolol Succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | 69097-409 | 69097-0409-0269097-0409-0769097-0409-15 | — |
| Nabumetone | Nabumetone 500 mg/1 | Tablet, Film coatedOral | 69097-965 | 69097-0965-0769097-0965-12 | — |
| Nabumetone | Nabumetone 750 mg/1 | Tablet, Film coatedOral | 69097-966 | 69097-0966-0769097-0966-12 | — |
Cipla USA Inc.: common questions
- What is Cipla USA Inc.'s NDC labeler code?
- 69097. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Cipla USA Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.